Additionally, ABCB5+ MSCs have been shown to modulate the immune response by reducing the secretion of TNF-α and IL-2, two cytokines critical in the development of GvHD, while concurrently increasing IL-10, a cytokine essential for limiting GvHD progression [40,99,100,101]. This evidence concerns the gene ABCB5 and graft versus host disease.